Back to search

Article

The assembly of cancer-specific ribosomes by the lncRNA <i>LISRR</i> suppresses melanoma anti-tumour immunity

2023-01-08

Abstract excerpt

Although immune checkpoint blockade (ICB) has revolutionized cancer treatment, resistance mechanisms limit its clinical benefit. Here we characterise LISRR , a cancer-specific lncRNA highly expressed in melanoma patients refractory to ICB. In cells undergoing (therapeutic) stress, LISRR recruits DAZAP1 (Deleted in AZoospermia Associated Protein 1) to polysomes and drives the assembly of a subset of ribosomes at...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
424c149b-88b1-5ad4-86ff-1928772260c9
DOI
10.1101/2023.01.06.523012
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The assembly of cancer-specific ribosomes by the lncRNA <i>LISRR</i> suppresses melanoma anti-tumour immunityDOI 10.1101/2023.01.06.523012
Select a neighboring publication to make it the new centre.